Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylaxis strategies for solid-organ transplantation.

R Soave1

  • 1Division of Infectious Diseases, Weill Medical College of Cornell University, New York, NY 10021, USA. rsoave@med.cornell.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|June 5, 2001
PubMed
Summary

Preventing infections after solid-organ transplantation involves managing immunosuppression and avoiding exposure to pathogens. Key strategies include environmental controls, prophylactic antibiotics, and targeted therapies for specific infections like Pneumocystis and Toxoplasma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fulminant and fatal encephalitis caused by Acanthamoeba in a kidney transplant recipient: case report and literature review.

Transplant infectious disease : an official journal of the Transplantation Society·2013
Same author

Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients.

Transplant infectious disease : an official journal of the Transplantation Society·2013
Same author

Renal dysfunction and hyperglycemia in a renal transplant recipient.

Transplant infectious disease : an official journal of the Transplantation Society·2001
Same author

Reiter syndrome following protracted symptoms of Cyclospora infection.

Emerging infectious diseases·2001
Same author

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Cyclosporiasis: clinical and histopathologic correlates.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1999

Area of Science:

  • Medical Science
  • Immunology
  • Infectious Diseases

Background:

  • Transplant recipients face significant infection risks due to immunosuppression.
  • Environmental exposures and endogenous flora are major infection sources.

Purpose of the Study:

  • To outline infection prevention strategies for solid-organ transplant recipients.
  • To detail methods for mitigating risks from epidemiologic exposures.

Main Methods:

  • Review of infection prevention protocols.
  • Discussion of prophylactic measures against common transplant-related infections.

Main Results:

  • Infection risk is multifactorial, influenced by immunosuppression and exposures.
  • Prophylaxis strategies are crucial for patient outcomes.

Related Experiment Videos

Conclusions:

  • Comprehensive infection prevention is vital post-transplantation.
  • Targeted prophylaxis reduces morbidity and mortality in transplant patients.